TY - JOUR
A1 - Rupp, Matthias
A1 - Proschak, Ewgenij
A1 - Schneider, Gisbert
T1 - Molecular similarity for machine learning in drug development : poster presentation
T2 - Chemistry central journal
N2 - Poster presentation In pharmaceutical research and drug development, machine learning methods play an important role in virtual screening and ADME/Tox prediction. For the application of such methods, a formal measure of similarity between molecules is essential. Such a measure, in turn, depends on the underlying molecular representation. Input samples have traditionally been modeled as vectors. Consequently, molecules are represented to machine learning algorithms in a vectorized form using molecular descriptors. While this approach is straightforward, it has its shortcomings. Amongst others, the interpretation of the learned model can be difficult, e.g. when using fingerprints or hashing. Structured representations of the input constitute an alternative to vector based representations, a trend in machine learning over the last years. For molecules, there is a rich choice of such representations. Popular examples include the molecular graph, molecular shape and the electrostatic field. We have developed a molecular similarity measure defined directly on the (annotated) molecular graph, a long-standing established topological model for molecules. It is based on the concepts of optimal atom assignments and iterative graph similarity. In the latter, two atoms are considered similar if their neighbors are similar. This recursive definition leads to a non-linear system of equations. We show how to iteratively solve these equations and give bounds on the computational complexity of the procedure. Advantages of our similarity measure include interpretability (atoms of two molecules are assigned to each other, each pair with a score expressing local similarity; this can be visualized to show similar regions of two molecules and the degree of their similarity) and the possibility to introduce knowledge about the target where available. We retrospectively tested our similarity measure using support vector machines for virtual screening on several pharmaceutical and toxicological datasets, with encouraging results. Prospective studies are under way.
Y1 - 2008
UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/96
UR - https://nbn-resolving.org/urn:nbn:de:hebis:30-54354
SN - 1752-153X
N1 - Fom 3rd German Conference on Chemoinformatics Goslar, Germany. 11-13 November 2007 ; © 2008 Rupp et al. This article is immediately and permanently available online. Unrestricted use, distribution and reproduction in any medium is permitted, provided the article is properly cited.
VL - 2008
IS - (Suppl 1):P10
SP - 1
EP - 1
PB - BioMed Central
CY - London
ER -